Who is sponsoring NCT07372118?

NCT07372118 is sponsored by Humanis Saglık Anonim Sirketi.

What drugs are being tested in NCT07372118?

Interventions in NCT07372118: Empagliflozin / Metformin HCl XR Tablets, Synjardy® XR (empagliflozin and metformin hydrochloride extended-release Tablets).

What condition does NCT07372118 study?

NCT07372118 studies Type 2 Diabetes Mellitus (T2DM).

Is NCT07372118 still recruiting?

NCT07372118 is currently completed. Last updated 28 January 2026.

Last reviewed 2026-01-28 · How we verify

NCT07372118

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition

Completed Phase 1 Last updated 28 January 2026

What this trial tests

Phase 1 trial testing Empagliflozin / Metformin HCl XR Tablets in Type 2 Diabetes Mellitus (T2DM) in 32 participants. Completed in 7 January 2026.

Timeline

27 September 2025

Primary endpoint
29 December 2025

7 January 2026

Quick facts

Lead sponsor	Humanis Saglık Anonim Sirketi
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	32
Start date	27 September 2025
Primary completion	29 December 2025
Estimated completion	7 January 2026
Sites	1 location across India

Drugs / interventions tested

Empagliflozin / Metformin HCl XR Tablets — full drug profile →
Synjardy® XR (empagliflozin and metformin hydrochloride extended-release Tablets) — full drug profile →

Conditions studied

Type 2 Diabetes Mellitus (T2DM) — all drugs for Type 2 Diabetes Mellitus (T2DM) →

Sponsor

Humanis Saglık Anonim Sirketi — full company profile →

Who can join

Adults 18 to 45, any sex, with Type 2 Diabetes Mellitus (T2DM). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in fast condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Empagliflozin / Metformin HCl XR Tablets

Trials testing the same drug.

NCT07266766 — Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tabl · Phase 1 · completed

Other recruiting trials for Type 2 Diabetes Mellitus (T2DM)

Currently open trials in the same condition.

NCT07533539 — Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration · Phase 1 · recruiting
NCT07366775 — A Telenursing Program to Support Diabetes Self-Management · NA · active not recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07465224 — A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus · Phase 2 · recruiting
NCT07442006 — Glycemic Variability of Combination Therapies in T2DM · Phase 4 · recruiting

Other Humanis Saglık Anonim Sirketi trials

Trials by the same sponsor.

NCT07278349 — Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets · Phase 1 · completed
NCT07266779 — Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Pr · Phase 1 · completed
NCT07266766 — Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tabl · Phase 1 · completed
NCT07266792 — Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpipraz · Phase 1 · completed
NCT07098585 — To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07372118 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Humanis Saglık Anonim Sirketi
Last refreshed: 28 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07372118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing